Dermatomyositis Advocacy Hub | UniteRare

At a Glance

Live from database

💊

Regulatory Watchboard

10 events

Jan 2027Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress

Duke University — NA

TrialNOT YET RECRUITING

Jun 2026Study of NM8074 in Patients with Dermatomyositis (DM)

NovelMed Therapeutics — PHASE2

TrialNOT YET RECRUITING

Apr 2026FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM)

National Institute of Environmental Health Sciences (NIEHS) — PHASE2

TrialNOT YET RECRUITING

Mar 2026Hypnotherapy for Needle-related Procedural Pain and Anxiety Management in a Pediatric Setting

Aarhus University Hospital — NA

TrialNOT YET RECRUITING

Jan 2026Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)

Restem, LLC. — PHASE2, PHASE3

TrialRECRUITING

Dec 2025Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis

Paean Biotechnology Inc. — PHASE2

TrialNOT YET RECRUITING

Nov 2025RCT of Tocilizumab for Anti-MDA5+DM

Peking Union Medical College Hospital — NA

TrialRECRUITING

Oct 2025Panniculitis in Dermatomyositis

University Hospital, Strasbourg, France

TrialRECRUITING

Sep 2025A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company — PHASE1

TrialRECRUITING

Jun 2025Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis

The Cleveland Clinic — PHASE2

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Copay cards

Copay Assistance1

TRIAMCINOLONE ACETONIDE

Bristol Myers Squibb

OpenContact for detailsApply ↗

View all support programs on disease page →

Approved Treatments

3 FDA-approved

Urea 39.5% With 2% Salicylic Acid

(UREA, SALICYLIC ACID)Orphan drugstandard

PureTek Corporation

FDA label ↗

Dermacure

(UREA 41%)Orphan drugstandard

Oncora Pharma, LLC

FDA label ↗

Urea Cream 40 Percent

(UREA)Orphan drugstandard

Method Pharmaceuticals, LLC

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

29 active trials

6Phase 3

1Phase 4

5Phase 2

4Phase 1

2N/A

10Unknown

1PHASE2, PHASE3

29Total recruiting

Search clinical trials for Dermatomyositis →

Recent News & Research

No recent news articles indexed yet for Dermatomyositis.
Search PubMed for Dermatomyositis →

Browse all Dermatomyositis news →

Specialist Network

Top 6 by expertise

Zhanguo Li

Peking University Institute of Rheuamotology and Immunology

Score 427 trials819 pubs

Samuel K Shinjo, PhD

Universidade de Sao Paulo - Rheumatology Division

Score 343 trials

YVES ALLENBACH, MD, PhD

Assistance Publique Hopitaux de Paris

Score 112 trials

Adam I Schiffenbauer, M.D., MD

National Institute of Environmental Health Sciences (NIEHS)

📍 WASHINGTON, DC

Score 74 trials

Lisa G Rider, M.D., AuD, CCC-A, PASC

National Institute of Environmental Health Sciences (NIEHS)

📍 AURORA, CO

Score 44 trials

Andrew L Mammen, M.D., M.D

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

📍 BALTIMORE, MD

Score 43 trials

View all Dermatomyositis specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰